Literature DB >> 32469922

The Community Navigator Study: Results from a feasibility randomised controlled trial of a programme to reduce loneliness for people with complex anxiety or depression.

Brynmor Lloyd-Evans1, Johanna Frerichs2, Theodora Stefanidou1, Jessica Bone1, Vanessa Pinfold2, Glyn Lewis1, Jo Billings1, Nick Barber1, Anjie Chhapia1, Beverley Chipp1, Rob Henderson3, Prisha Shah1, Anna Shorten3, Maria Giorgalli1, James Terhune1, Rebecca Jones1, Sonia Johnson1.   

Abstract

BACKGROUND: Loneliness is common among people with mental health problems and predicts poorer recovery from depression and anxiety. Needs for support with loneliness and social relationships are often under-addressed in mental health services. The Community Navigator programme was designed to reduce loneliness for adults (aged 18 and above) with complex depression or anxiety who were using secondary mental health services. Acceptability and feasibility of the programme and a trial evaluation were tested in a feasibility randomised controlled trial with qualitative evaluation.
METHODS: Forty participants with depression or anxiety using secondary mental health services were recruited from mental health services in two London sites and randomised to receive: the Community Navigator programme over six months in addition to routine care (n = 30); or routine care (n = 10). Measures of loneliness, depression, other clinical and social outcomes and service use were collected at baseline and six-months follow-up. Levels of engagement in the programme and rates of trial recruitment and retention were assessed. Programme delivery was assessed through session logs completed by Community Navigators. The acceptability of the programme was explored through qualitative interviews (n = 32) with intervention group participants, their family and friends, programme providers and other involved staff.
RESULTS: Forty participants were recruited in four months from 65 eligible potential participants asked. No one withdrew from the trial. Follow-up interviews were completed with 35 participants (88%). Process records indicated the programme was delivered as intended: there was a median of seven meetings with their Community Navigator (of a maximum ten) per treatment group participant. Qualitative interviews indicated good acceptability of the programme to stakeholders, and potential utility in reducing loneliness and depression and anxiety.
CONCLUSIONS: A definitive, multi-site randomised controlled trial is recommended to evaluate the effectiveness and cost-effectiveness of the Community Navigator programme for people with complex anxiety and depression in secondary mental health services.

Entities:  

Year:  2020        PMID: 32469922     DOI: 10.1371/journal.pone.0233535

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  10 in total

Review 1.  Interventions to improve social connections: a systematic review and meta-analysis.

Authors:  Dino Zagic; Viviana M Wuthrich; Ronald M Rapee; Nine Wolters
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-11-18       Impact factor: 4.328

Review 2.  Interventions to improve social circumstances of people with mental health conditions: a rapid evidence synthesis.

Authors:  Phoebe Barnett; Thomas Steare; Zainab Dedat; Stephen Pilling; Paul McCrone; Martin Knapp; Eleanor Cooke; Daphne Lamirel; Sarah Dawson; Peter Goldblatt; Stephani Hatch; Claire Henderson; Rachel Jenkins; T K; Karen Machin; Alan Simpson; Prisha Shah; Martin Stevens; Martin Webber; Sonia Johnson; Brynmor Lloyd-Evans
Journal:  BMC Psychiatry       Date:  2022-04-28       Impact factor: 4.144

3.  Is social support pre-treatment associated with prognosis for adults with depression in primary care?

Authors:  Joshua E J Buckman; Rob Saunders; Ciaran O'Driscoll; Zachary D Cohen; Joshua Stott; Gareth Ambler; Simon Gilbody; Steven D Hollon; Tony Kendrick; Edward Watkins; Nicola Wiles; David Kessler; Nomsa Chari; Ian R White; Glyn Lewis; Stephen Pilling
Journal:  Acta Psychiatr Scand       Date:  2021-02-16       Impact factor: 7.734

4.  The experience of loneliness among people with a "personality disorder" diagnosis or traits: a qualitative meta-synthesis.

Authors:  Sarah Ikhtabi; Alexandra Pitman; Gigi Toh; Mary Birken; Eiluned Pearce; Sonia Johnson
Journal:  BMC Psychiatry       Date:  2022-02-17       Impact factor: 3.630

5.  Exploring how and why social prescribing evaluations work: a realist review.

Authors:  Megan Elliott; Mark Davies; Julie Davies; Carolyn Wallace
Journal:  BMJ Open       Date:  2022-04-05       Impact factor: 2.692

6.  A controlled evaluation of the effect of social prescribing programs on loneliness for adults in Queensland, Australia (protocol).

Authors:  G A Dingle; L S Sharman; S Hayes; D Chua; J R Baker; C Haslam; J Jetten; S A Haslam; T Cruwys; N McNamara
Journal:  BMC Public Health       Date:  2022-07-19       Impact factor: 4.135

7.  Protective factors against depressive symptoms among Brazilian healthcare workers during the initial stages of the COVID-19 pandemic: a cross-sectional study.

Authors:  Eric Marques Januario; Lucianne Jobim Valdivia; Antonio Augusto Schmitt Júnior; Felipe Cesar de Almeida Claudino; Augusto Mädke Brenner; Neusa Sica da Rocha
Journal:  BMJ Open       Date:  2022-09-16       Impact factor: 3.006

8.  Influences on participation in a programme addressing loneliness among people with depression and anxiety: findings from the Community Navigator Study.

Authors:  Johanna Frerichs; Jo Billings; Nick Barber; Anjie Chhapia; Beverley Chipp; Prisha Shah; Anna Shorten; Theodora Stefanidou; Sonia Johnson; Brynmor Lloyd Evans; Vanessa Pinfold
Journal:  BMC Psychiatry       Date:  2020-11-26       Impact factor: 3.630

9.  Symptoms of anxiety/depression during the COVID-19 pandemic and associated lockdown in the community: longitudinal data from the TEMPO cohort in France.

Authors:  Astrid Juhl Andersen; Murielle Mary-Krause; Joel José Herranz Bustamante; Mégane Héron; Tarik El Aarbaoui; Maria Melchior
Journal:  BMC Psychiatry       Date:  2021-07-28       Impact factor: 3.630

10.  Behavioural Activation for Social IsoLation (BASIL+) trial (Behavioural activation to mitigate depression and loneliness among older people with long-term conditions): Protocol for a fully-powered pragmatic randomised controlled trial.

Authors:  Lauren Burke; Elizabeth Littlewood; Samantha Gascoyne; Dean McMillan; Carolyn A Chew-Graham; Della Bailey; Claire Sloan; Caroline Fairhurst; Kalpita Baird; Catherine Hewitt; Andrew Henry; Eloise Ryde; Leanne Shearsmith; Peter Coventry; Suzanne Crosland; Elizabeth Newbronner; Gemma Traviss-Turner; Rebecca Woodhouse; Andrew Clegg; Tom Gentry; Andrew Hill; Karina Lovell; Sarah Dexter Smith; Judith Webster; David Ekers; Simon Gilbody
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.